Related Articles
Transporter‑mediated drug‑drug interactions involving poly (ADP‑ribose) polymerase inhibitors (Review)
Roles of DNA damage repair and precise targeted therapy in renal cancer (Review)
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer (Review)
SIRT1 and gynecological malignancies (Review)